🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparative study of efficacy and safety of ketamine, clonidine, mixture of...
Status
Unknown
Location
Santa Casa de São Paulo
Start Date
2008-04
Trial ID
NCT00661063
Treatments Being Tested
This study is to evaluate the therapeutic equivalence and safety of Taro Pr...
Status
Completed
Location
Catawba Research, LLC
Start Date
2019-03-20
Trial ID
NCT04134273
Treatments Being Tested
Periodontal disease (commonly called gum disease) is generally treated by d...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00529555
Treatments Being Tested
This study is designed to evaluate the analgesic safety and efficacy of stu...
Status
Completed
Location
Lotus Clinical Research, LLC
Start Date
2015-01
Trial ID
NCT02324985
Treatments Being Tested
This is a Phase 3 efficacy and safety study of CD07805/47 topical gel in su...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2011-05
Trial ID
NCT01355471
Treatments Being Tested
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...
Status
Completed
Location
Alliance Dermatology
Start Date
2015-05
Trial ID
NCT02616614
Treatments Being Tested
This study evaluates the safety and efficacy of once-daily application of C...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02547441
Treatments Being Tested
This study looks at whether a topical gel called 0.33% brimonidine can redu...
Status
Completed
Location
Istanbul Training and Research Hospital, Department of Dermatology
Start Date
2025-05-01
Trial ID
NCT07431476
Treatments Being Tested
This study is to evaluate the therapeutic equivalence and safety of Clindam...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02595034
Treatments Being Tested
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Dose-Ranging, ...
Status
Terminated
Location
Zai Lab Site 5013
Start Date
2024-05-22
Trial ID
NCT06380907